Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mahalakshmi Ganesapandian"'
Autor:
Mahalakshmi Ganesapandian, Alphienes Stanley Xavier, Kirubakaran Ramakrishnan, Sandhiya Selvarajan, Sapan Kumar Behera, Saibal Das
Publikováno v:
Journal of Clinical and Translational Hepatology
Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine practice. The target of such vaccination is to induce the immune response in the host, resulting in the prevention of replication of HBV. There are several immu
Autor:
Sandhiya Selvarajan, Mahalakshmi Ganesapandian, Priyadharsini Rajendran, Kiruthika Sivagourounadin
Publikováno v:
Current drug safety. 17(1)
Background and Objective: Identification of the offending drug is crucial and challenging in cases of severe cutaneous adverse drug reactions (CADR) like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Poor reproducibility and va
Autor:
Sandhiya Selvarajan, Kirubakaran Ramakrishnan, Mahalakshmi Ganesapandian, Saibal Das, Hemachandren Munuswamy, Sapan Kumar Behera
Publikováno v:
European Journal of Clinical Pharmacology. 76:133-135
Publikováno v:
Indian Journal of Pharmacology
AIM: The aim of the study was to compare the dose-adjusted plasma levels of carbamazepine (CBZ) among expressers and nonexpressers of cytochrome P450 3A5 (CYP3A5)* 3 genotypes. SUBJECTS AND METHODS: The study was carried out in 100 epileptic patients
Autor:
Ganesapandian, Mahalakshmi1 (AUTHOR), Ramasamy, Kesavan1 (AUTHOR), Adithan, Surendiran1 (AUTHOR), Narayan, Sunil2 (AUTHOR)
Publikováno v:
Indian Journal of Pharmacology. Nov/Dec2019, Vol. 51 Issue 6, p384-388. 5p.
Autor:
Das, Saibal, Behera, Sapan Kumar, Ramakrishnan, Kirubakaran, Ganesapandian, Mahalakshmi, Munuswamy, Hemachandren, Selvarajan, Sandhiya
Publikováno v:
European Journal of Clinical Pharmacology; Jan2020, Vol. 76 Issue 1, p133-135, 3p, 1 Graph